Tests a communication method for shared treatment decisions in type 2 diabetes
Tests a doctor-patient communication method in 250 adults with type 2 diabetes.
Key facts
- Who runs it
- Yunxuan Li
- Where
- Xiamen, ChinaSee the site
- Trial code
- Registry title
- Nudge-Based Shared Decision Making and Self-Management in Type 2 Diabetes: A Randomized Trial
- Status
- Recruiting
- People taking part
- 250 people, planned
- Started
- 1 Nov 2025
- Planned end
- Jun 2026
- Type of study
- Interventional, 2 groups
- Treatments tested
- Linguistic Nudging Training
- Medication Preference App
- Standard Diabetes Care
- Record updated
- 28 November 2025
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults with type 2 diabetes who can use a smartphone. It tests whether a doctor communication method helps patients manage their diabetes.
- Age
- 18 years or older
- Sex
- All sexes can join.
- Disease stage
- Confirmed type 2 diabetes. Normal thinking and memory (Mini-Cog score of 3 or more).
Main reasons for not taking part
- Severe sudden complications such as ketoacidosis or hyperosmolar coma
- Documented cognitive impairment such as dementia or Alzheimer's
- Taking part in another clinical trial
- Life expectancy under 6 months
- Pregnancy or breastfeeding
The registry criteria, word for word
Show all 10 criteriaShow less
Who can take part
- Confirmed diagnosis of type 2 diabetes
- Age ≥ 18 years
- Normal cognitive function (assessed by Mini-Cog score ≥ 3)
- Basic smartphone operation ability (can independently use WeChat)
- Willing to participate and sign informed consent
Who cannot take part
- Documented cognitive impairment (dementia, Alzheimer's, etc.)
- Severe acute complications (e.g., ketoacidosis, hyperosmolar coma)
- Currently participating in other clinical trials
- Life expectancy < 6 months
- Pregnancy or lactation
Where in China
- Xiang'an Hospital Affiliated to Xiamen UniversityXiamen, ChinaContact: Yunxuan Li, StudentTaking people
About the trial
What the trial wants to find out
This study aims to test whether a communication strategy called "linguistic nudging" can help doctors and patients with type 2 diabetes make better treatment decisions together, and whether this improves patients' ability to manage their condition.
Read full original descriptionShow less
What will happen in the study? - 250 adults with type 2 diabetes from Xiang'an Hospital (Xiamen) will be randomly assigned to one of two groups:
Intervention group:Doctors will receive special training in "linguistic nudging" techniques to encourage shared decision-making. Patients will use a mobile app to record medication preferences, and doctors will adjust advice based on these preferences.
Control group:Patients will receive standard diabetes care without these additional strategies.
- All participants will be followed for 6 months.
What is the study aiming to find out?
The main goal is to see if patients in the intervention group:
Better follow medication plans Improve blood sugar monitoring Have better blood sugar control Feel more satisfied with doctor-patient communication
Why is this important? Good self-management is key to controlling diabetes, but many patients struggle with it. Effective communication during shared decision-making may empower patients to manage their condition day-to-day with greater confidence.
Patient safety and rights:
Participation is completely voluntary All personal information will be kept strictly confidential Medical support will be provided if any health problems occur during the study Participants may withdraw at any time
This research has been approved by the Ethics Committee of Xiang'an Hospital (Approval date: October 2025).
The 2 groups in the trial
- Linguistic Nudging GroupTreatment being tested
Receives communication training + preference app
Treatment: Linguistic Nudging Training, Medication Preference App, and Standard Diabetes Care
- Standard Care GroupOther group
Receives routine diabetes management only
Treatment: Standard Diabetes Care
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- Effect of Nudge-Based Shared Decision Making on Self-Management Among Patients With Type 2 Diabetes: A Randomized Controlled Trial
- Plain-language title
- Tests a communication method for shared treatment decisions in type 2 diabetesGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 12 November 2026.
- Record updated
- 28 November 2025